8-K/ALeadership Changes

PFIZER INC 8-K/A Report, Executive Changes (Dec 21, 2017)

Filed December 21, 2017For Securities:PFE

Summary

This 8-K/A filing from Pfizer Inc. (PFE) amends a previous report to detail compensation adjustments for key executives following recent leadership changes. Specifically, it clarifies the new compensation for Albert Bourla, who was appointed Chief Operating Officer effective January 1, 2018. His annual base salary has increased, and his target annual cash incentive opportunity has been adjusted to reflect his new role, aligning with company salary midpoint guidelines. Furthermore, the filing discloses significant performance-based incentive awards granted to Chairman and CEO Ian Read and Group President John D. Young. These awards, primarily in the form of Performance-Based Total Shareholder Return Units (PTSRUs), are designed to incentivize long-term value creation and align executive compensation with shareholder returns. The details of these awards, including vesting conditions tied to continued employment and specific total shareholder return targets over a five-year period, are outlined.

Key Highlights

  • 1Albert Bourla's annual base salary increased from $1,180,000 to $1,400,000 effective January 1, 2018.
  • 2Albert Bourla's annual target cash incentive opportunity increased to $1,406,100 for 2018.
  • 3Chairman and CEO Ian Read received a Special Performance-Based Incentive Award of PTSRUs valued at $8.0 million, vesting based on employment and company total shareholder return.
  • 4Group President John D. Young received a $2.0 million PTSRU award and a $2.0 million restricted stock unit (RSU) award, both vesting based on employment and company total shareholder return (for PTSRUs) or time (for RSUs).
  • 5PTSRU awards for Mr. Read and Mr. Young are tied to the company's total shareholder return being at least 25% higher on average over a 30-day period within a five-year performance window.
  • 6Both PTSRU awards include provisions for vesting upon death, termination without cause, or long-term disability, with modified service conditions.
  • 7This filing serves as an amendment to a previous 8-K filed on November 13, 2017, to finalize compensation details.

Frequently Asked Questions

Albert Bourla's annual base salary was increased to $1,400,000, and his annual target cash incentive opportunity was adjusted to $1,406,100 for 2018, effective January 1, 2018, reflecting his new role as Chief Operating Officer.

Both executives were granted Performance-Based Total Shareholder Return Units (PTSRUs). Ian Read received $8.0 million in PTSRUs, while John D. Young received $2.0 million in PTSRUs and an additional $2.0 million in restricted stock units (RSUs).

The PTSRUs vest contingent upon continued employment through specific dates and the company achieving a total shareholder return of at least 25% higher on average for 30 consecutive trading days within a five-year performance period. Specific employment duration requirements vary between Mr. Read and Mr. Young.

Yes, the PTSRU awards have provisions that waive the service condition upon the recipient's death, termination without cause, or long-term disability. In such cases, the award would still need to meet the performance condition to vest and settle.